Compare · head to head
LifeStance Health vs Myriad Genetics
LifeStance Health ranks higher overall — 360 rank 80 vs 12.
Myriad Genetics leads on Value (51 vs 33) and Quality (62 vs 53). LifeStance Health leads on Growth (76 vs 44), Safety (62 vs 16) and Sentiment (58 vs 30).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Health Care Providers & Services | Biotechnology |
| Size | Medium | Medium |
| ISIN | US53228F1012 | US62855J1043 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 80 | 12 |
| Value | 33 | 51 |
| Quality | 53 | 62 |
| Growth | 76 | 44 |
| Safety | 62 | 16 |
| Sentiment | 58 | 30 |
| Quality details | ||
| Profitability | 38 | 56 |
| Cash Truth | 67 | 69 |
LifeStance Health vs National ResearchLifeStance Health vs Kestra Medical TechnologiesLifeStance Health vs NateraLifeStance Health vs Lumexa ImagingAdd a third stock →
Full analyses: LifeStance Health · Myriad Genetics
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100